Quidel | QDEL - Cash And Equivalent


Quidel reported $169.8M in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Abbott USD 6.8B 1.72B Mar/2026
Agilent USD 1.76B 31M Dec/2025
Avanos Medical USD 65.6M 24.2M Mar/2026
Becton, Dickinson and Co. USD 740M 99M Dec/2025
Bruker USD 293.1M 201.1M Sep/2025
Cerus USD 19.96M 4.29M Dec/2025
Charles River Laboratories USD 213.77M 6.67M Dec/2025
Danaher USD 5.7B 1.09B Mar/2026
Haemonetics USD 363.37M 66.94M Dec/2025
Illumina USD 1.42B 368M Dec/2025
IQVIA Holdings USD 1.95B 33M Mar/2026
Merit Medical Systems USD 488.08M 41.68M Mar/2026
Mettler Toledo International USD 69.06M 7.24M Sep/2025
Myriad Genetics USD 149.6M 4.2M Dec/2025
Neogen USD 159.9M 14.56M Dec/2025
OraSure Technologies USD 199.28M 17.2M Dec/2025
Pacific Biosciences Of California USD 279.51M 223.04M Dec/2025
Quidel USD 169.8M 71.7M Dec/2025
Revvity USD 919.86M 11.53M Dec/2025
STAAR Surgical USD 153.15M 23M Dec/2025
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Waters USD 587.83M 128.71M Dec/2025